You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-TNF therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hidradenitis Suppurativa Trial (Upadacitinib, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa
  • (no location specified)
May 26, 2023

Pneumococcal Vaccination in Patients With Anti-TNF Alpha Therapy

Not yet recruiting
  • Pneumococcal Vaccine
  • Pneumococcal vaccine
  • Pontoise, France
    Internal Medicine Department - NOVO Hospital - Pontoise site
Mar 28, 2023

IBD, Crohn Disease, Colitis, Ulcerative Trial in Belgium, Netherlands, Spain (Infliximab, Adalimumab)

Recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • Infliximab
  • Adalimumab
  • Gent, Belgium
  • +6 more
May 17, 2022

IBD, Crohn Disease, Ulcerative Colitis Trial in Hartford, Cincinnati, Columbus (2'-Fucosyllactose, Placebo)

Recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • Hartford, Connecticut
  • +2 more
Jan 31, 2022

Nerve Conduction Studies in Ankylosing Spondylitis

Completed
  • Anti - TNF Therapy
  • +2 more
  • Anti-TNF agents
  • Conventional therapy users for the last 5 years
  • Istanbul, Turkey
    Istanbul Physical Medicine and Rehabilitation Training and resea
Jun 21, 2021

Crohn's Disease Trial (Placebo, ABT-494)

Completed
  • Crohn's Disease
  • (no location specified)
Jul 30, 2021

Combined Microbiota and Metabolic Signature in Ulcerative

Not yet recruiting
  • Ulcerative Colitis
  • (no location specified)
Jan 26, 2023

Spondyloarthritis, Crohn Disease, Ulcerative Colitis Trial in Pessac (blood sample, stool samples, food questionnaire)

Completed
  • Spondyloarthritis
  • +2 more
  • blood sample
  • +4 more
  • Pessac, France
    CHU de Bordeaux - service d'Hépato-gastroentérologie
May 25, 2022

Rates of Dementia and Alzheimer's Disease in Participants

Completed
  • Dementia
  • Alzheimer Disease
  • Titusville, New Jersey
    Janssen R&D
Oct 15, 2021

Pediatric Crohn's Disease Trial in United States (Methotrexate, Sugar pill ())

Completed
  • Pediatric Crohn's Disease
  • Birmingham, Alabama
  • +31 more
Jun 21, 2022

Juvenile Idiopathic Arthritis Associated Uveitis Trial in Cairo (biologic DMARDs)

Active, not recruiting
  • Juvenile Idiopathic Arthritis Associated Uveitis
  • biologic DMARDs
  • Cairo, Egypt
    Faculty of medicine, Cairo university
Sep 12, 2022

Ankylosing Spondylitis Trial in Germany (Golimumab, Celecoxib)

Completed
  • Ankylosing Spondylitis
  • Altenburg, Germany
  • +18 more
Jan 26, 2021

Rheumatoid Arthritis Trial (ABT-494, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • (no location specified)
Jul 29, 2021

HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

Recruiting
  • Drug Monitoring
  • Inflammatory Bowel Diseases
  • Tumor necrosis factor (TNF)-alpha inhibitors
  • Valladolid, Spain
    Hospital Universitario Rio Hortega
Aug 8, 2023

Rheumatoid Arthritis Trial in Abu Dhabi (Anti-TNF, JAK inhibitor)

Not yet recruiting
  • Rheumatoid Arthritis
  • Abu Dhabi, United Arab Emirates
    Abu Dhabi Stem Cells Center
May 17, 2022

Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to

Terminated
  • Ulcerative Colitis
  • Stanford, California
  • +1 more
Dec 17, 2020

Efficacy of Anti-TNF Therapy in AS: An Inception Cohort Study

Active, not recruiting
  • Ankylosing Spondylitis
  • Axial Spondyloarthritis
    • Adana, Turkey
    • +12 more
    Feb 16, 2021

    Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)

    Recruiting
    • Hidradenitis Suppurativa
    • Lutikizumab
    • Placebo
    • Phoenix, Arizona
    • +54 more
    Jan 26, 2023

    Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis Trial in Madrid (Anti-TNF: Infliximab (Infusion), Anti-TNF

    Active, not recruiting
    • Crohn's Disease
    • +2 more
    • Anti-TNF: Infliximab (Infusion)
    • +2 more
    • Madrid, Spain
      Hospital Universitario de La Princesa
    Mar 15, 2022

    Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)

    Completed
    • Crohn's Disease
    • Ulcerative Colitis
    • Immuno monitoring
    • Montpellier, France
      University hospital
    Dec 13, 2022

    Melanoma Trial in Toulouse (Nivolumab+Ipilimumab in combination with Anti TNF-a Certolizumab, Nivolumab+Ipilimumab in

    Active, not recruiting
    • Melanoma
    • Nivolumab+Ipilimumab in combination with Anti TNF-α Certolizumab
    • Nivolumab+Ipilimumab in combination with Anti TNF-α Infliximab
    • Toulouse, France
      Institut Claudius Regaud IUCT-ONCOPOLE
    Nov 18, 2022

    Ulcerative Colitis Trial (Appendectomy, Infliximab)

    Not yet recruiting
    • Ulcerative Colitis
    • (no location specified)
    Jun 27, 2023

    Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)

    Active, not recruiting
    • Colitis,Ulcerative
    • Discontinuation of anti-TNF treatment
    • Continuation of anti-TNF treatment
    • Alesund, Norway
    • +18 more
    Jul 13, 2022

    A Multicenter, Prospective, Long-term, Observational Registry of

    Active, not recruiting
    • Crohn's Disease
    • +3 more
    • Anti TNF therapy including infliximab
    • No Biologics
    • Mobile, Alabama
    • +61 more
    Jan 31, 2023

    IGRA in Screening and Monitoring for TB During Anti TNF Therapy

    Completed
    • Inflammatory Bowel Disease
    • +4 more
      • Hong Kong, Hong Kong
        Prince of Wales Hospital
      Apr 27, 2020